Cargando…

Country score tool to assess readiness and guide evidence generation of immunization programs in aging adults in Europe

OBJECTIVES: Delaying of policies for immunization of aging adults, low vaccine uptake, and the lack of supportive evidence at the national level could diminish the value in health and economics of such programs. This study aims to develop a “country score tool” to assess readiness and to facilitate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pham, Thi Hao, Beck, Ekkehard, Postma, Maarten J., Németh, Bertalan, Ágh, Tamás, de Waure, Chiara, Salisbury, David M., Nutma, Nynke, van der Schans, Jurjen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869118/ https://www.ncbi.nlm.nih.gov/pubmed/36699900 http://dx.doi.org/10.3389/fpubh.2022.1080678

Ejemplares similares

Pneumococcal Vaccination for Children in Asian Countries: A Systematic Review of Economic Evaluation Studies
por: Zakiyah, Neily, et al.
Publicado: (2020)

Inequalities in Rotavirus Vaccine Uptake in Ethiopia: A Decomposition Analysis
por: Wondimu, Abrham, et al.
Publicado: (2020)

Translation and performance of the Finnish Diabetes Risk Score for detecting undiagnosed diabetes and dysglycaemia in the Indonesian population
por: Rokhman, M. Rifqi, et al.
Publicado: (2022)

Investing in the Prevention of Communicable Disease Outbreaks: Fiscal Health Modelling—The Tool of Choice for Assessing Public Finance Sustainability
por: van der Schans, Simon, et al.
Publicado: (2023)

Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate
por: van der Schans, Jurjen, et al.
Publicado: (2015)

Economic evaluations of mammography to screen for breast cancer in low- and middle-income countries: A systematic review
por: Icanervilia, Ajeng V, et al.
Publicado: (2022)

Reconstructing the Effectiveness of Policy Measures to Avoid Next-Wave COVID-19 Infections and Deaths Using a Dynamic Simulation Model: Implications for Health Technology Assessment
por: Hagens, Arnold, et al.
Publicado: (2022)

Cost-effectiveness of non-communicable disease prevention in Southeast Asia: a scoping review
por: Nguyen, Thi-Phuong-Lan, et al.
Publicado: (2023)

An Updated Analysis of the Impact of HPV Vaccination Based on Long-term Effectiveness in the Netherlands
por: Luttjeboer, Jos, et al.
Publicado: (2023)

HTA51 Challenges and Opportunities of Health Technology Assessment in Older Adult Immunization
por: van Dorst, P, et al.
Publicado: (2022)

School health in Europe: a review of workforce expenditure across five countries
por: van der Pol, Simon, et al.
Publicado: (2020)

Criteria and Scoring Functions Used in Multi-criteria Decision Analysis and Value Frameworks for the Assessment of Rare Disease Therapies: A Systematic Literature Review
por: Zelei, Tamás, et al.
Publicado: (2021)

COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for Turkey
por: Hagens, Arnold, et al.
Publicado: (2021)

Cost-Effectiveness of Treatments in Children With Attention-Deficit/Hyperactivity Disorder: A Continuous-Time Markov Modeling Approach
por: Freriks, Roel D., et al.
Publicado: (2019)

Seasonal influenza in children: Costs for the health system and society in Europe
por: Villani, Leonardo, et al.
Publicado: (2022)

Is the radiological community within Europe ready for audit?
Publicado: (2011)

CAI: China is ready, how is about Europe
por: Chen, Xin
Publicado: (2022)

Population birth data and pandemic readiness in Europe
por: Rodin, Urelija, et al.
Publicado: (2021)

Monitoring physical impact and recovery of pancreatic cancer treatment using consumer wearable health data: A case report
por: van der Schans, Cees P, et al.
Publicado: (2023)

Delayed payment schemes in Central-Eastern Europe and Middle-East
por: Ádám, Ildikó, et al.
Publicado: (2022)

Psychometric properties of kidney disease quality of life-36 (KDQOL-36) in dialysis patients in Indonesia
por: Rokhman, M. Rifqi, et al.
Publicado: (2022)

Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?
por: Kovács, Sándor, et al.
Publicado: (2022)

Unprecedented rise of monkeypox in Europe and America: Are Asian countries ready for a new outbreak during the ongoing COVID-19 pandemic?
por: Khan, Sakirul, et al.
Publicado: (2022)

Interactive robots for health in Europe: Technology readiness and adoption potential
por: Östlund, Britt, et al.
Publicado: (2023)

Adaptation and validation of the HIV Knowledge Questionnaire-18 for the general population of Indonesia
por: Arifin, Bustanul, et al.
Publicado: (2022)

The knowledge mapping of HIV/AIDS in Indonesians living on six major islands using the Indonesian version of the HIV-KQ-18 instrument
por: Arifin, Bustanul, et al.
Publicado: (2023)

Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries
por: Tachkov, Konstantin, et al.
Publicado: (2022)

Ecodatacube.eu: analysis-ready open environmental data cube for Europe
por: Witjes, Martijn, et al.
Publicado: (2023)

A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic
por: Ágh, Tamás, et al.
Publicado: (2021)

Feeding Babies at the Beginnings of Urbanization in Central Europe
por: Rebay-Salisbury, Katharina, et al.
Publicado: (2021)

Planning and Organization of the COVID-19 Vaccination Campaign: An Overview of Eight European Countries
por: Cadeddu, Chiara, et al.
Publicado: (2022)

Can cost–effectiveness principles be ignored in urgent times?
por: Kaló, Zoltán, et al.
Publicado: (2021)

1152. Quantifying the health equity related public health impact of national immunisation programmes
por: Biundo, Eliana, et al.
Publicado: (2023)

A utility of model input uncertainty analysis in transferring tobacco control‐related economic evidence to countries with scarce resources: results from the EQUIPT study
por: Németh, Bertalan, et al.
Publicado: (2018)

Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands
por: Hagendijk, Marije E., et al.
Publicado: (2021)

Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries—A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses
por: Jakab, Ivett, et al.
Publicado: (2020)

P68 Investing in the Prevention of Infectious Disease Outbreaks: Fiscal Health Modelling for Assessing the Public Investment Case
por: Schöttler, M, et al.
Publicado: (2022)

Maternal immunization country readiness: a checklist approach
por: Giles, Michelle L., et al.
Publicado: (2020)

Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries
por: Dimitrova, Maria, et al.
Publicado: (2022)

Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study
por: Ágh, Tamás, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1cb36tl2fflc85efr6gb1ju60s